Drug General Information
Drug ID	D0H4DW
Former ID	DNC014321
Drug Name	9-Ethyl-beta-carboline
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530824]
Structure		Download 2D MOL 3D MOL
Formula	C13H12N2
Canonical SMILES	CCN1C2=CC=CC=C2C3=C1C=NC=C3
InChI	1S/C13H12N2/c1-2-15-12-6-4-3-5-10(12)11-7-8-14-9-13(11)15/h3-9H,2H2,1H3
InChIKey	BMGUCVPPDGYFRV-UHFFFAOYSA-N
PubChem Compound ID	14221745
Target and Pathway
Target(s)	Acetylcholinesterase	Target Info	Inhibitor	[530824]
KEGG Pathway	Glycerophospholipid metabolism
	Cholinergic synapse
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database	ATF-2 transcription factor network
PathWhiz Pathway	Phospholipid Biosynthesis
WikiPathways	Monoamine Transport
	Biogenic Amine Synthesis
	Acetylcholine Synthesis
	Integrated Pancreatic Cancer Pathway
References
Ref 530824	J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.
Ref 530824	J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.